Found 23 matching trials
Impact of PCSK9 Inhibitors on Coronary Plaque Composition and Vulnerability Assessed by Optical Coherence Tomography PHASE4 The study is a prospective, open-label, randomized, single-center study inv...
Show More Location
Beijing Anzhen Hospital
Learn More & Join Trial
Evaluation of the Effect of Long-term Lipid-lowering Therapy in STEMI Patients With Coronavirus Infection COVID-19 NA It is planned to include 200 patients hospitalized with primary myocardial ...
Show More Location
Valentin Oleynikov
Learn More & Join Trial
Intensive Lipid-lowering in Patients With STEMI and NSTEMI (Germany on Target) NA Intensive Lipid-Lowering Therapy guided by a cloud-based Software System (C...
Show More Location
University Hospital Jena
Learn More & Join Trial
Assessment of the Effects of Long-term Lipid-lowering Therapy in Patients With Primary STEMI or NSTEMI PHASE4 In a single-center, open-label, prospective, controlled, clinical study, it...
Show More Location
Valentin Oleynikov
Learn More & Join Trial
Very Early PCSK9 Inhibition for Acute Myocardial Infarction NA Acute myocardial infarction (AMI) remains a major cause of morbidity and mo...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464) N/A This study is being performed to evaluate what variants of lipid-lowering t...
Show More Location
Multiple Locations
Learn More & Join Trial
Intensive Lipid-lowering for Plaque and Major Adverse Cardiovascular Events in Low to Intermediate 10-year ASCVD Risk Population NA Current guidelines recommend moderate-intensity lipid-lowering therapy (goa...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Randomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a) NA Lipoprotein(a) \[Lp(a)\] is an independent risk factor for cardiovascular d...
Show More Location
Lipidambulanz, InterdisziplinÀres Stoffwechsel-Centrum, CVK, Charite
Learn More & Join Trial
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT PHASE4 This randomized controlled study will evaluate whether icosapent ethyl (IPE...
Show More Learn More & Join Trial
Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia PHASE4 This study aims to evaluate the effectiveness and safety of implementing a ...
Show More Location
Multiple Locations
Learn More & Join Trial